全文获取类型
收费全文 | 147238篇 |
免费 | 13593篇 |
国内免费 | 10337篇 |
专业分类
耳鼻咽喉 | 1368篇 |
儿科学 | 1661篇 |
妇产科学 | 1712篇 |
基础医学 | 17528篇 |
口腔科学 | 2451篇 |
临床医学 | 18914篇 |
内科学 | 22514篇 |
皮肤病学 | 1934篇 |
神经病学 | 8233篇 |
特种医学 | 5275篇 |
外国民族医学 | 89篇 |
外科学 | 15870篇 |
综合类 | 24539篇 |
现状与发展 | 44篇 |
一般理论 | 25篇 |
预防医学 | 9737篇 |
眼科学 | 4453篇 |
药学 | 14612篇 |
114篇 | |
中国医学 | 8084篇 |
肿瘤学 | 12011篇 |
出版年
2024年 | 484篇 |
2023年 | 2372篇 |
2022年 | 5843篇 |
2021年 | 7614篇 |
2020年 | 5675篇 |
2019年 | 4894篇 |
2018年 | 5189篇 |
2017年 | 4603篇 |
2016年 | 4449篇 |
2015年 | 6581篇 |
2014年 | 8103篇 |
2013年 | 7254篇 |
2012年 | 10662篇 |
2011年 | 11600篇 |
2010年 | 7196篇 |
2009年 | 5737篇 |
2008年 | 7618篇 |
2007年 | 7592篇 |
2006年 | 7374篇 |
2005年 | 7454篇 |
2004年 | 4957篇 |
2003年 | 4482篇 |
2002年 | 3893篇 |
2001年 | 3427篇 |
2000年 | 3565篇 |
1999年 | 3734篇 |
1998年 | 2404篇 |
1997年 | 2362篇 |
1996年 | 1804篇 |
1995年 | 1745篇 |
1994年 | 1492篇 |
1993年 | 956篇 |
1992年 | 1282篇 |
1991年 | 1073篇 |
1990年 | 935篇 |
1989年 | 872篇 |
1988年 | 731篇 |
1987年 | 656篇 |
1986年 | 594篇 |
1985年 | 446篇 |
1984年 | 241篇 |
1983年 | 187篇 |
1982年 | 116篇 |
1981年 | 125篇 |
1980年 | 90篇 |
1979年 | 127篇 |
1977年 | 52篇 |
1974年 | 66篇 |
1973年 | 60篇 |
1972年 | 63篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
腮腺良性和恶性多形性腺瘤的超声研究 总被引:1,自引:0,他引:1
目的研究腮腺良性和恶性多形性腺瘤的超声特点,为临床医师诊治提供有效依据。方法选取腮腺良性多形性腺瘤患者79例和恶性多形性腺瘤患者15例,对其肿块的大小、硬度、内部回声、彩色多普勒血流显像(CDFI)特点结合病理学诊断进行对照研究。结果恶性多形性腺瘤的声像图特点与良性多形性腺瘤相似,但其肿瘤相对较大,质地更硬,内部回声分布更紊乱。不同性质的肿瘤的大小和质地有显著性差异,(P<0.01)。结论多形性腺瘤的超声诊断主要依据二维图像之特点。当多形性腺瘤大于3.0 cm,硬度较硬,内部回声分布不均多提示恶性。 相似文献
52.
Background It is estimated that skin cancers cost $33 million per annum to the New Zealand healthcare system. Basal cell carcinoma and squamous cell carcinoma are the commonest types of non melanoma skin cancers (NMSCs). Anecdotal evidence indicates that there has been a doubling in the incidence of NMSCs in New Zealand over the last decade. Because of the high incidence mandatory reporting of NMSCs to the National Cancer Registry is not required. This lack of accurate data has led to poor health care policies and strategies including funding and workforce planning. Aims The aims of this study are to (1) present the latest statistics on NMSCs in New Zealand, including the incidence across different regions over the last decade, patient demographics, anatomic distribution of NMSCs, incidence and sites of metastasis, and disease‐specific survival; to (2) the histopathology of NMSCs, including surgical margins, histologic grade, and perineural, lymphatic, and vascular invasion; and (3) the relative role of different faculties treating NMSCs. Method This project has been approved by the multi‐centre ethics committee. A retrospective review was conducted from patients’ histology records from public and private pathology laboratories within defined catchment areas. Criterion for analysis is a confirmed diagnosis of NMSC treated surgically. A Microsoft Access database is created that will facilitate subsequent data retrieval and analysis. Results and Conclusion It is hoped that this up‐to‐date data will form the framework for the development of sound and sustainable healthcare policies of management of NMSCs including management strategies and workforce planning, and research direction on this common disease. 相似文献
53.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
54.
55.
56.
57.
Zhao-Jin Chen Mamun Al-Mahtab Salimar Rahman Ngiap-Chuan Tan Nan Luo Bee-Choo Tai 《Quality of life research》2010,19(9):1343-1348
Purpose
Hepatitis B virus (HBV) is endemic in Bangladesh, and the quality of life (QoL) of these patients remains unknown as there is no instrument available in the native language. In this study, we translated the 56-item Hepatitis Quality of Life Questionnaire (HQLQ) into Bengali and evaluated its validity and reliability. 相似文献58.
目的 探讨纯氧和空气复苏对新生儿发育的影响,为新生儿复苏用氧选择提供依据.方法 对2005年1月-2007年1月在保定市妇幼保健院进行窒息复苏的30例患儿在24个月时进行随访,依据复苏用氧浓度分为纯氧复苏组(20例)和空气复苏组(10例),内容包括出生时胎龄、出生体重、身长、头围、阿氏评分(1 min,5 min)、心率(1 min,5 min)、随访时体重、身长、头围及运动发育标志(坐、爬、站、走时间).结果 出生时患儿身体数据差异无统计学意义,24个月随访,患儿身高、体重、头围及运动发育标志差异均无统计学意义(P>0.05).结论 空气复苏对新生儿窒息患者是安全有效的. 相似文献
59.
近十年高血压病中医研究概况 总被引:1,自引:0,他引:1
为了促进中医药治疗高血压病的进一步发展,深入进行高血压病中医的病因病机、治法方药、作用机制的相关研究,本文对近十年有代表性的文献进行归纳分析。 相似文献
60.